GO
Loading...

Government Agencies

More

  • WASHINGTON/ MUMBAI, June 27- India's Ranbaxy Laboratories Ltd has received approval from the U.S. Food and Drug Administration to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its India facilities dented investor sentiment.

  • U.S. gas prices to rise if biofuel mandate not cut -CBO Thursday, 26 Jun 2014 | 6:39 PM ET

    WASHINGTON, June 26- U.S. gasoline prices could rise by up to 26 cents a gallon by 2017 if the Environmental Protection Agency does not lower the ambitious targets in a federal biofuel use mandate, the Congressional Budget Office said on Thursday.

  • *U.S.-listed shares of Barclays fall on fraud lawsuit. *GoPro shares jump over 30 percent in first day after IPO. NEW YORK, June 26- U.S. stocks ended slightly lower on Thursday after the president of the Federal Reserve Bank of St. Louis said interest-rate increases should come sooner rather than later.

  • U.S. FDA seeks ideas for nanotech use in livestock feed Thursday, 26 Jun 2014 | 1:28 PM ET

    CHICAGO, June 26- The U.S. Food and Drug Administration is opening the door for livestock feed manufacturers and pharmaceutical companies to roll out nanotechnology products that could make animals gain weight faster or absorb medications more quickly.

  • *Financial stocks slide on U.S. lawsuit vs Barclays. NEW YORK, June 26- U.S. stocks fell on Thursday after a top Federal Reserve official said interest rates should rise by early 2015, while the pound gained on speculation that UK rates were set to go higher, even as the Bank of England took only mild steps on Thursday to tighten lending.

  • European shares fall, traders cite U.S. Fed official Thursday, 26 Jun 2014 | 11:27 AM ET

    *Barclays sags on U.S. fraud lawsuit linked to stock trading. The market was also pegged back by weakness in banking shares, led by a steep drop in Barclays after the New York Attorney General filed a lawsuit against it. "I think it is mainly Bullard," said Andy Ash, director at Monument Securities.

  • *U.S.-listed shares of Barclays fall on fraud lawsuit. *GoPro to make Nasdaq debut after pricing IPO at top of range. NEW YORK, June 26- U.S. stocks fell on Thursday following comments from a top Federal Reserve official that interest rate increases should come sooner rather than later.

  • LYNCHBURG, Va., June 26- The U.S. jobless rate is likely giving an accurate read on the amount of slack in the labor market, with an unusually high level of long-term unemployment reflecting those who lack skills needed to find work, a top Federal Reserve official said on Thursday.

  • Lynchburg, Va., June 26- U.S. labor market data since 2008 reflects structural trends rather cyclical changes, a Federal Reserve official said on Thursday, adding that there seems to be no more slack now than is usually associated with current unemployment levels.

  • Nikkei ekes out gains on Fed rate views; Rakuen soars Thursday, 26 Jun 2014 | 2:16 AM ET

    TOKYO, June 26- Japan's Nikkei rose marginally on Thursday, crawling back from a one-week low as weak U.S. gross domestic product data supported by views that the U.S. Federal Reserve will keep interest rates low for longer. Rakuten Inc soared on a report it is preparing to enter the low-cost carrier business.

  • DIARY - Top Economic Events to July 9 Wednesday, 25 Jun 2014 | 8:01 PM ET

    WASHINGTON- Federal Reserve Bank of St. Louis President James Bullard speaks in New York on "Monetary policy and Income inequality" at the Charles Peter McColough Roundtable Series on International Economics. LONDON- Bank of England publishes half-yearly Financial Stability Report and Governor Mark Carney holds news conference- 0930 GMT.

  • Representative Bob Goodlatte, chairman of the House Judiciary Committee, and Senator Lamar Alexander, ranking member on the Senate's Committee on Health, Education, Labor& Pensions, wrote to the White House's Office of Management and Budget requesting justification for the cost-benefit analysis on the proposed rule by the Food and Drug Administration.

  • "I don't think anybody knows what do," said Michael F. Jacobson, executive director of CSPI, which calculated the numbers using data it obtained from the FDA. The FDA said it has been studying the drinks for several years and is evaluating the deaths. " This does not necessarily mean that the energy drink caused the death, "an FDA spokesperson said.

  • WASHINGTON, June 25- An advisory panel to the U.S. Food and Drug Administration recommended on Wednesday that AstraZeneca Plc be required to submit further clinical data before its experimental ovarian cancer drug is approved.

  • NEW YORK, June 25- The U.S. dollar slid to a one-month low against a basket of major currencies on Wednesday after weak U.S. gross domestic product and durable goods orders data signalled the likelihood of a continued dovish stance from the Federal Reserve.

  • WASHINGTON, June 25- An advisory panel to the U.S. Food and Drug Administration recommended on Wednesday that AstraZeneca Plc be required to submit further clinical data before its experimental ovarian cancer drug is approved.

  • June 25- The U.S. Food and Drug Administration warned on Wednesday that popular acne products such as Proactiv and Neutrogena can cause rare but serious and life-threatening allergic reactions.

  • This year it rejected plans by Citigroup to buy back $6.4 billion of shares and boost dividends, and also objected to plans from the U.S. units of three European banks: HSBC, RBS and Santander.

  • NEW YORK, June 25- The U.S. dollar slid to a one-month low against a basket of major currencies on Wednesday after weak U.S. gross domestic product and durable goods orders data signalled the likelihood of a continued dovish stance from the Federal Reserve.

  • WASHINGTON, June 25- Federal Reserve Chair Janet Yellen wants to see U.S. wages climb at a much brisker clip to boost consumer spending and help workers recoup ground they lost in the last recession, but she'll have to fend off policymakers who fear that could cause inflation to surge.